SCM
MESO

Sio Capital Management’s Mesoblast MESO Stock Holding History

Sio Capital Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,600
Closed -$230K – 58
2024
Q4 		$230K Buy
+11,600
New +$128K 0.06% 46
2022
Q1 		– Sell
-13,330
Closed -$128K – 77
2021
Q4 		$128K Buy
+13,330
New +$155K 0.04% 68

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Sio Capital Management's MESO Position: Q1 2025 in Review

Sio Capital Management sold out of Mesoblast (MESO) in Q1 2025, closing a stake of 11,600 shares — an estimated $230K sold.

Sio Capital Management first reported a position in MESO in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q4 2024. 68 funds tracked by Wall St. Rank hold MESO as of Q1 2025.

  • Sio Capital Management reported no remaining Mesoblast position as of Q1 2025 after selling out during the quarter.
  • Sio Capital Management sold 11,600 Mesoblast shares in Q1 2025, an estimated $230K.
  • Sio Capital Management first reported a position in Mesoblast in Q4 2021 and held it in 2 quarters.
  • Sio Capital Management's Mesoblast position peaked at $230K in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Mesoblast as of Q1 2025.

Based on Sio Capital Management's 13F filing for Q1 2025, filed 15 May 2025.